Latest filing published 11 Jan 2018 for BioSyent Inc., €17k.
No signal scores available.
This profile gathers the share dealings of Peter John Weiler in BioSyent Inc. We count 2 filings; the first trade dates from 14 August 2017 and the latest from 8 January 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 11 January 2018 came the latest disclosure, an option exercise for €17k in BioSyent Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations